| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.838 | 0.003 | 0.838 | DNA synthesis inhibitor | 0.279 0.051 DBMET00498 0.416 0.02 DBMET00499 0.412 0.02 DBMET00493 | ||
| 0.755 | 0.002 | 0.755 | RNA-directed DNA polymerase inhibitor | 0.337 0.026 DBMET00498 0.473 0.012 DBMET00499 0.421 0.016 DBMET00493 | ||
| 0.648 | 0.001 | 0.648 | Adenosine deaminase inhibitor | 0.061 0.02 DBMET00498 0.085 0.008 DBMET00499 0.11 0.004 DBMET00493 | ||
| 0.631 | 0.002 | 0.631 | NADH dehydrogenase inhibitor | 0.223 0.009 DBMET00498 0.456 0.004 DBMET00499 0.411 0.004 DBMET00493 | ||
| 0.576 | 0.003 | 0.576 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.244 0.045 DBMET00498 0.222 0.057 DBMET00499 0.199 0.073 DBMET00493 | ||
| 0.568 | 0.003 | 0.568 | Adenosine A1 receptor antagonist | 0.112 0.021 DBMET00498 0.354 0.005 DBMET00499 0.287 0.007 DBMET00493 | ||
| 0.567 | 0.005 | 0.734 | Cyclic AMP phosphodiesterase inhibitor | 0.291 0.045 DBMET00498 0.734 0.003 DBMET00499 0.49 0.007 DBMET00493 | DBMET00499 | |
| 0.496 | 0.004 | 0.514 | DNA polymerase I inhibitor | 0.17 0.039 DBMET00498 0.444 0.005 DBMET00499 0.514 0.004 DBMET00493 | DBMET00493 | |
| 0.502 | 0.029 | 0.502 | Immunostimulant | 0.32 0.073 DBMET00498 0.159 0.147 DBMET00499 0.179 0.134 DBMET00493 | ||
| 0.415 | 0.001 | 0.415 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.047 0.004 DBMET00498 0.078 0.003 DBMET00499 0.069 0.003 DBMET00493 | ||
| 0.457 | 0.045 | 0.457 | Immunosuppressant | 0.202 0.195 DBMET00493 | ||
| 0.418 | 0.007 | 0.418 | Adenylate cyclase inhibitor | 0.346 0.01 DBMET00499 0.175 0.032 DBMET00493 | ||
| 0.414 | 0.004 | 0.414 | Adenosine A3 receptor antagonist | 0.148 0.013 DBMET00498 0.348 0.004 DBMET00499 0.279 0.006 DBMET00493 | ||
| 0.405 | 0.002 | 0.405 | Nicotinic acid receptor 1 agonist | 0.207 0.004 DBMET00499 0.162 0.004 DBMET00493 | ||
| 0.4 | 0.002 | 0.4 | Thymidine kinase inhibitor | 0.098 0.006 DBMET00498 0.189 0.003 DBMET00499 0.151 0.004 DBMET00493 | ||
| 0.382 | 0.006 | 0.382 | UDP-glucose 4-epimerase inhibitor | 0.116 0.046 DBMET00498 0.196 0.019 DBMET00499 0.149 0.029 DBMET00493 | ||
| 0.383 | 0.008 | 0.383 | Peptidyltransferase inhibitor | 0.26 0.044 DBMET00499 | ||
| 0.371 | 0.004 | 0.371 | Adenosine A2 receptor antagonist | 0.068 0.041 DBMET00498 0.319 0.005 DBMET00499 0.236 0.008 DBMET00493 | ||
| 0.404 | 0.043 | 0.439 | Immunomodulator | 0.439 0.034 DBMET00498 0.192 0.174 DBMET00499 0.219 0.142 DBMET00493 | DBMET00498 | |
| 0.358 | 0.004 | 0.358 | Antimetabolite | 0.168 0.011 DBMET00498 0.191 0.01 DBMET00499 0.146 0.012 DBMET00493 | ||
| 0.349 | 0.004 | 0.349 | Adenosine A2a receptor antagonist | 0.065 0.04 DBMET00498 0.248 0.007 DBMET00499 0.193 0.01 DBMET00493 | ||
| 0.345 | 0.014 | 0.345 | Cytidine deaminase inhibitor | 0.194 0.05 DBMET00498 0.155 0.072 DBMET00499 | ||
| 0.333 | 0.003 | 0.333 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.136 0.009 DBMET00498 0.182 0.007 DBMET00499 0.114 0.012 DBMET00493 | ||
| 0.331 | 0.004 | 0.331 | DNA repair enzyme inhibitor | 0.199 0.009 DBMET00498 0.237 0.006 DBMET00499 0.168 0.019 DBMET00493 | ||
| 0.328 | 0.004 | 0.328 | Carbamoyl phosphate synthetase inhibitor | 0.109 0.018 DBMET00498 0.199 0.007 DBMET00499 0.174 0.009 DBMET00493 | ||
| 0.376 | 0.064 | 0.376 | Vasodilator, peripheral | |||
| 0.312 | 0.02 | 0.312 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.266 0.048 DBMET00498 0.249 0.067 DBMET00499 0.297 0.027 DBMET00493 | ||
| 0.287 | 0.008 | 0.287 | DNA directed RNA polymerase inhibitor | 0.095 0.063 DBMET00498 0.168 0.019 DBMET00499 | ||
| 0.275 | 0.014 | 0.275 | Alkylator | 0.128 0.061 DBMET00499 0.11 0.077 DBMET00493 | ||
| 0.265 | 0.008 | 0.265 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.259 | 0.005 | 0.259 | Argininosuccinate synthase inhibitor | 0.064 0.034 DBMET00498 0.2 0.008 DBMET00499 0.129 0.014 DBMET00493 | ||
| 0.286 | 0.032 | 0.286 | DNA methylase inhibitor | |||
| 0.26 | 0.007 | 0.26 | Phosphofructokinase-1 inhibitor | 0.083 0.039 DBMET00498 0.142 0.02 DBMET00499 0.108 0.029 DBMET00493 | ||
| 0.374 | 0.127 | 0.5 | DNA directed DNA polymerase inhibitor | 0.5 0.082 DBMET00498 0.328 0.149 DBMET00499 | DBMET00498 | |
| 0.346 | 0.104 | 0.346 | Antibacterial | |||
| 0.246 | 0.01 | 0.246 | Adenylate kinase inhibitor | 0.122 0.042 DBMET00498 0.163 0.022 DBMET00499 0.195 0.016 DBMET00493 | ||
| 0.212 | 0.002 | 0.212 | Thymidine phosphorylase inhibitor | 0.157 0.002 DBMET00498 0.11 0.003 DBMET00499 0.036 0.008 DBMET00493 | ||
| 0.204 | 0.005 | 0.232 | Biliverdin reductase inhibitor | 0.129 0.012 DBMET00498 0.232 0.004 DBMET00499 0.155 0.009 DBMET00493 | DBMET00499 | |
| 0.265 | 0.068 | 0.265 | Interleukin agonist | 0.173 0.146 DBMET00493 | ||
| 0.216 | 0.027 | 0.216 | Hexokinase inhibitor | 0.123 0.114 DBMET00499 | ||
| 0.197 | 0.01 | 0.197 | Glutamate dehydrogenase inhibitor | 0.081 0.043 DBMET00498 0.139 0.018 DBMET00499 0.131 0.019 DBMET00493 | ||
| 0.281 | 0.106 | 0.281 | Transcription factor NF kappa B inhibitor | |||
| 0.186 | 0.022 | 0.186 | MAP3K9 inhibitor | 0.149 0.061 DBMET00499 0.173 0.032 DBMET00493 | ||
| 0.164 | 0.005 | 0.164 | Purinergic P2X1 antagonist | 0.143 0.008 DBMET00498 0.083 0.023 DBMET00499 0.104 0.015 DBMET00493 | ||
| 0.171 | 0.014 | 0.308 | Phosphodiesterase I inhibitor | 0.12 0.027 DBMET00498 0.308 0.005 DBMET00499 0.239 0.007 DBMET00493 | DBMET00499 | |
| 0.236 | 0.088 | 0.236 | DNA damaging | |||
| 0.153 | 0.009 | 0.153 | Acyl-CoA dehydrogenase inhibitor | 0.049 0.043 DBMET00498 0.081 0.022 DBMET00499 0.125 0.012 DBMET00493 | ||
| 0.264 | 0.12 | 0.264 | Vasodilator, coronary | 0.235 0.149 DBMET00499 0.232 0.153 DBMET00493 | ||
| 0.164 | 0.023 | 0.2 | Death-associated protein kinase 1 inhibitor | 0.143 0.052 DBMET00498 0.2 0.007 DBMET00493 | DBMET00493 | |
| 0.14 | 0.001 | 0.14 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.07 0.006 DBMET00498 0.133 0.001 DBMET00499 0.136 0.001 DBMET00493 | ||
| 0.187 | 0.05 | 0.187 | MAP kinase kinase 5 inhibitor | 0.165 0.1 DBMET00493 | ||
| 0.137 | 0.001 | 0.137 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.034 0.004 DBMET00498 0.066 0.002 DBMET00499 0.048 0.003 DBMET00493 | ||
| 0.138 | 0.005 | 0.138 | Phosphoglycerate kinase inhibitor | 0.033 0.027 DBMET00499 0.032 0.029 DBMET00493 | ||
| 0.18 | 0.05 | 0.18 | Protein kinase stimulant | |||
| 0.196 | 0.071 | 0.196 | DNA methyltransferase I inhibitor | |||
| 0.167 | 0.046 | 0.266 | MAP kinase 3 inhibitor | 0.176 0.037 DBMET00499 0.266 0.006 DBMET00493 | DBMET00493 | |
| 0.163 | 0.043 | 0.163 | Adenylate cyclase stimulant | 0.128 0.105 DBMET00498 0.144 0.073 DBMET00499 0.147 0.067 DBMET00493 | ||
| 0.213 | 0.094 | 0.572 | Vasodilator | 0.572 0.007 DBMET00499 0.283 0.054 DBMET00493 | DBMET00499 | |
| 0.106 | 0.004 | 0.147 | AICAR transformylase inhibitor | 0.072 0.009 DBMET00498 0.147 0.003 DBMET00499 0.119 0.004 DBMET00493 | DBMET00499 | |
| 0.121 | 0.021 | 0.121 | HIV-1 reverse transcriptase inhibitor | 0.118 0.023 DBMET00498 | ||
| 0.112 | 0.014 | 0.112 | Protein kinase C eta inhibitor | |||
| 0.098 | 0.003 | 0.098 | Adenosine kinase inhibitor | |||
| 0.113 | 0.024 | 0.455 | CDK1/cyclin B1 inhibitor | 0.062 0.058 DBMET00498 0.093 0.031 DBMET00499 0.455 0.004 DBMET00493 | DBMET00493 | |
| 0.103 | 0.015 | 0.103 | Ornithine carbamoyltransferase inhibitor | 0.047 0.043 DBMET00498 0.1 0.016 DBMET00499 0.073 0.024 DBMET00493 | ||
| 0.1 | 0.014 | 0.1 | Protein kinase C beta inhibitor | 0.072 0.044 DBMET00493 | ||
| 0.115 | 0.03 | 0.115 | Phosphodiesterase 6D inhibitor | 0.1 0.053 DBMET00499 0.093 0.068 DBMET00493 | ||
| 0.128 | 0.046 | 0.153 | Protein kinase C gamma inhibitor | 0.153 0.03 DBMET00493 | DBMET00493 | |
| 0.077 | 0.004 | 0.077 | Adenosine A1 receptor agonist | |||
| 0.135 | 0.065 | 0.203 | Alpha-N-acetylglucosaminidase inhibitor | 0.203 0.033 DBMET00498 0.133 0.066 DBMET00499 0.196 0.035 DBMET00493 | DBMET00498 | |
| 0.092 | 0.023 | 0.092 | Ribonucleotide reductase inhibitor | |||
| 0.208 | 0.143 | 0.287 | Hypoxia-inducible factor 1 alpha inhibitor | 0.188 0.167 DBMET00499 0.287 0.072 DBMET00493 | DBMET00493 | |
| 0.091 | 0.027 | 0.091 | Protein kinase C alpha inhibitor | |||
| 0.067 | 0.004 | 0.067 | Uridine phosphorylase inhibitor | 0.056 0.006 DBMET00498 0.033 0.015 DBMET00499 | ||
| 0.09 | 0.028 | 0.096 | Phosphodiesterase VI inhibitor | 0.086 0.033 DBMET00499 0.096 0.023 DBMET00493 | DBMET00493 | |
| 0.174 | 0.114 | 0.174 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.208 | 0.148 | 0.208 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.075 | 0.016 | 0.332 | Adenosine A2b receptor antagonist | 0.045 0.04 DBMET00498 0.332 0.003 DBMET00499 0.134 0.007 DBMET00493 | DBMET00499 | |
| 0.095 | 0.036 | 0.487 | Phosphodiesterase 3A inhibitor | 0.487 0.003 DBMET00498 0.185 0.01 DBMET00499 0.192 0.009 DBMET00493 | DBMET00498 | |
| 0.125 | 0.066 | 0.134 | Aldehyde dehydrogenase inhibitor | 0.134 0.058 DBMET00493 | DBMET00493 | |
| 0.066 | 0.009 | 0.066 | Fumarate hydratase inhibitor | 0.058 0.011 DBMET00499 0.041 0.018 DBMET00493 | ||
| 0.101 | 0.045 | 0.231 | Protein kinase A inhibitor | 0.077 0.063 DBMET00499 0.231 0.01 DBMET00493 | DBMET00493 | |
| 0.096 | 0.041 | 0.096 | Hematopoietic | |||
| 0.076 | 0.026 | 0.076 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.046 | 0.004 | 0.046 | Adenosine A3 receptor agonist | |||
| 0.056 | 0.015 | 0.056 | Guanylate cyclase inhibitor | |||
| 0.058 | 0.019 | 0.081 | Thymidylate synthase inhibitor | 0.081 0.007 DBMET00498 0.075 0.009 DBMET00499 0.063 0.015 DBMET00493 | DBMET00498 | |
| 0.21 | 0.173 | 0.21 | Interleukin 2 agonist | |||
| 0.042 | 0.006 | 0.042 | Purinergic P2Y15 antagonist | 0.028 0.02 DBMET00498 0.033 0.012 DBMET00499 0.041 0.006 DBMET00493 | ||
| 0.039 | 0.002 | 0.232 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.037 0.002 DBMET00498 0.062 0.001 DBMET00499 0.232 0.001 DBMET00493 | DBMET00493 | |
| 0.097 | 0.06 | 0.097 | Protein kinase C mu inhibitor | |||
| 0.094 | 0.06 | 0.158 | Alpha 2d adrenoreceptor antagonist | 0.142 0.011 DBMET00499 0.158 0.007 DBMET00493 | DBMET00493 | |
| 0.035 | 0.002 | 0.076 | Purine nucleoside phosphorylase inhibitor | 0.021 0.003 DBMET00498 0.035 0.002 DBMET00499 0.076 0.001 DBMET00493 | DBMET00493 | |
| 0.042 | 0.012 | 0.042 | Purinergic P2X agonist | |||
| 0.084 | 0.053 | 0.084 | T cell inhibitor | |||
| 0.092 | 0.063 | 0.099 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.099 0.055 DBMET00499 0.082 0.077 DBMET00493 | DBMET00499 | |
| 0.121 | 0.092 | 0.121 | Protein kinase C nu inhibitor | 0.119 0.094 DBMET00499 | ||
| 0.033 | 0.005 | 0.033 | Adenosine A2 receptor agonist | 0.015 0.013 DBMET00493 | ||
| 0.051 | 0.024 | 0.973 | Phosphodiesterase 3B inhibitor | 0.973 0.001 DBMET00498 0.266 0.004 DBMET00499 0.205 0.005 DBMET00493 | DBMET00498 | |
| 0.044 | 0.018 | 0.044 | Antibiotic Aminoglycoside-like | |||
| 0.089 | 0.063 | 0.089 | Protein kinase C delta inhibitor | |||
| 0.029 | 0.005 | 0.029 | Adenosine A2a receptor agonist | |||
| 0.144 | 0.121 | 0.15 | Psychostimulant | 0.15 0.117 DBMET00493 | DBMET00493 | |
| 0.026 | 0.005 | 0.026 | Purinergic P2 agonist | |||
| 0.026 | 0.005 | 0.026 | Purinergic receptor agonist | |||
| 0.025 | 0.005 | 0.025 | S-adenosyl-L-homocysteine hydrolase inhibitor | |||
| 0.022 | 0.005 | 0.022 | Adenosine A2b receptor agonist | |||
| 0.023 | 0.005 | 0.023 | Purinergic P2Y1 agonist | 0.014 0.013 DBMET00493 | ||
| 0.022 | 0.005 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.015 DBMET00499 0.02 0.008 DBMET00493 | ||
| 0.082 | 0.065 | 0.082 | Transcription factor NF kappa B stimulant | |||
| 0.047 | 0.03 | 0.047 | Purinergic P2X4 antagonist | |||
| 0.02 | 0.005 | 0.02 | Purinergic P2Y agonist | |||
| 0.025 | 0.011 | 0.025 | Inosine monophosphate dehydrogenase 1 inhibitor | |||
| 0.06 | 0.046 | 0.521 | CDK1/cyclin B inhibitor | 0.094 0.027 DBMET00499 0.521 0.004 DBMET00493 | DBMET00493 | |
| 0.016 | 0.003 | 0.016 | Purinergic P2Y2 agonist | |||
| 0.07 | 0.06 | 0.094 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.078 0.04 DBMET00499 0.094 0.018 DBMET00493 | DBMET00493 | |
| 0.087 | 0.077 | 0.556 | Xanthine oxidase inhibitor | 0.556 0.003 DBMET00498 0.306 0.007 DBMET00499 0.268 0.01 DBMET00493 | DBMET00498 | |
| 0.119 | 0.109 | 0.119 | Acetylcholine M1 receptor antagonist | |||
| 0.05 | 0.04 | 0.05 | Protein 50S ribosomal subunit inhibitor | |||
| 0.204 | 0.197 | 0.421 | Histamine release inhibitor | 0.28 0.135 DBMET00499 0.421 0.065 DBMET00493 | DBMET00493 | |
| 0.041 | 0.035 | 0.088 | Purinergic P2Y antagonist | 0.088 0.011 DBMET00498 0.052 0.025 DBMET00499 | DBMET00498 | |
| 0.039 | 0.038 | 0.039 | Phosphorylase inhibitor | |||
| 0.061 | 0.063 | 0.248 | Phosphodiesterase V inhibitor | 0.209 0.005 DBMET00498 0.237 0.005 DBMET00499 0.248 0.005 DBMET00493 | DBMET00493 | |
| 0.037 | 0.04 | 0.038 | CF transmembrane conductance regulator antagonist | 0.038 0.034 DBMET00493 | DBMET00493 | |
| 0.146 | 0.151 | 0.247 | Growth factor agonist | 0.247 0.033 DBMET00493 | DBMET00493 | |
| 0.029 | 0.037 | 0.053 | Inosine monophosphate dehydrogenase inhibitor | 0.053 0.013 DBMET00498 | DBMET00498 | |
| 0.061 | 0.071 | 0.263 | MAP3K7 inhibitor | 0.263 0.004 DBMET00493 | DBMET00493 | |
| 0.137 | 0.147 | 0.206 | Platelet aggregation inhibitor | 0.17 0.107 DBMET00499 0.206 0.077 DBMET00493 | DBMET00493 | |
| 0.054 | 0.066 | 0.188 | Cyclin B3 inhibitor | 0.188 0.007 DBMET00493 | DBMET00493 | |
| 0.053 | 0.064 | 0.117 | Phosphodiesterase 1A inhibitor | 0.117 0.007 DBMET00499 0.117 0.007 DBMET00493 | DBMET00493 | |
| 0.032 | 0.044 | 0.055 | MAP3K5 inhibitor | 0.055 0.009 DBMET00493 | DBMET00493 | |
| 0.022 | 0.042 | 0.072 | Phosphodiesterase 6B inhibitor | 0.069 0.004 DBMET00498 0.069 0.004 DBMET00499 0.072 0.004 DBMET00493 | DBMET00493 | |
| 0.013 | 0.035 | 0.672 | Purinergic P2Y12 antagonist | 0.672 0.002 DBMET00498 0.055 0.006 DBMET00499 | DBMET00498 | |
| 0.151 | 0.174 | 0.41 | Cardiotonic | 0.41 0.027 DBMET00499 0.318 0.049 DBMET00493 | DBMET00499 | |
| 0.053 | 0.076 | 0.232 | Phosphodiesterase 5A inhibitor | 0.211 0.005 DBMET00498 0.232 0.005 DBMET00499 0.209 0.005 DBMET00493 | DBMET00499 | |
| 0.068 | 0.093 | 0.1 | MAP kinase kinase 7 inhibitor | 0.081 0.044 DBMET00498 0.085 0.034 DBMET00499 0.1 0.013 DBMET00493 | DBMET00493 | |
| 0.054 | 0.079 | 0.09 | Telomerase inhibitor | 0.09 0.039 DBMET00493 | DBMET00493 | |
| 0.003 | 0.029 | 0.035 | DNA polymerase III subunit alpha inhibitor | 0.035 0.001 DBMET00498 0.018 0.002 DBMET00499 0.011 0.003 DBMET00493 | DBMET00498 | |
| 0.046 | 0.073 | 0.134 | Phosphodiesterase 1B inhibitor | 0.068 0.032 DBMET00498 0.134 0.008 DBMET00499 0.117 0.011 DBMET00493 | DBMET00499 | |
| 0.071 | 0.099 | 0.13 | Alcohol dehydrogenase inhibitor | 0.13 0.029 DBMET00499 0.109 0.044 DBMET00493 | DBMET00499 | |
| 0.007 | 0.037 | 0.018 | Glucose-dependent insulinotropic receptor antagonist | 0.018 0.004 DBMET00493 | DBMET00493 | |
| 0.016 | 0.052 | 0.04 | Phosphodiesterase 6G inhibitor | 0.04 0.004 DBMET00498 0.031 0.007 DBMET00499 0.032 0.006 DBMET00493 | DBMET00498 | |
| 0.016 | 0.052 | 0.04 | Phosphodiesterase 6H inhibitor | 0.04 0.004 DBMET00498 0.031 0.007 DBMET00499 0.032 0.006 DBMET00493 | DBMET00498 | |
| 0.07 | 0.108 | 0.318 | Uric acid excretion stimulant | 0.318 0.005 DBMET00498 0.222 0.01 DBMET00499 0.153 0.022 DBMET00493 | DBMET00498 | |
| 0.175 | 0.213 | 0.188 | MAP kinase kinase 3 inhibitor | 0.188 0.163 DBMET00493 | DBMET00493 | |
| 0.06 | 0.099 | 0.114 | Histamine N-methyltransferase inhibitor | 0.077 0.07 DBMET00499 0.114 0.034 DBMET00493 | DBMET00493 | |
| 0.035 | 0.077 | 0.7 | Cyclin B2 inhibitor | 0.25 0.004 DBMET00499 0.7 0.002 DBMET00493 | DBMET00493 | |
| 0.037 | 0.083 | 0.074 | Phosphodiesterase 6C inhibitor | 0.074 0.004 DBMET00498 0.064 0.006 DBMET00499 0.061 0.008 DBMET00493 | DBMET00498 | |
| 0.038 | 0.085 | 0.214 | Purinergic P2 antagonist | 0.214 0.006 DBMET00498 0.055 0.053 DBMET00499 | DBMET00498 | |
| 0.033 | 0.082 | 0.044 | Glucose-6-phosphate isomerase inhibitor | 0.044 0.04 DBMET00498 | DBMET00498 | |
| 0.039 | 0.087 | 0.723 | Cyclin B1 inhibitor | 0.274 0.004 DBMET00499 0.723 0.002 DBMET00493 | DBMET00493 | |
| 0.014 | 0.063 | 0.16 | Histamine H3 receptor agonist | 0.102 0.006 DBMET00499 0.16 0.005 DBMET00493 | DBMET00493 | |
| 0.038 | 0.087 | 0.974 | Phosphodiesterase III inhibitor | 0.974 0.001 DBMET00498 0.736 0.002 DBMET00499 0.355 0.004 DBMET00493 | DBMET00498 | |
| 0.068 | 0.119 | 0.38 | GABA C receptor agonist | 0.257 0.013 DBMET00498 0.26 0.013 DBMET00499 0.38 0.005 DBMET00493 | DBMET00493 | |
| 0.121 | 0.179 | 0.13 | Heat shock protein 70 antagonist | 0.13 0.119 DBMET00493 | DBMET00493 | |
| 0.005 | 0.062 | 0.058 | Egl nine homolog 2 inhibitor | 0.024 0.004 DBMET00499 0.058 0.003 DBMET00493 | DBMET00493 | |
| 0.034 | 0.092 | 0.641 | Cyclin B inhibitor | 0.231 0.004 DBMET00499 0.641 0.003 DBMET00493 | DBMET00493 | |
| 0.041 | 0.104 | 0.347 | Check point kinase 1 inhibitor | 0.06 0.059 DBMET00498 0.347 0.005 DBMET00499 0.331 0.005 DBMET00493 | DBMET00499 | |
| 0.181 | 0.244 | 0.235 | Calcium channel activator | 0.235 0.165 DBMET00493 | DBMET00493 | |
| 0.01 | 0.076 | 0.049 | Alpha 2d adrenoreceptor agonist | 0.035 0.007 DBMET00499 0.049 0.005 DBMET00493 | DBMET00493 | |
| 0.068 | 0.134 | 0.178 | GABA C receptor rho-1 antagonist | 0.091 0.076 DBMET00498 0.156 0.019 DBMET00499 0.178 0.012 DBMET00493 | DBMET00493 | |
| 0.045 | 0.113 | 0.096 | Interferon inducer | 0.096 0.014 DBMET00498 | DBMET00498 | |
| 0.066 | 0.138 | 0.126 | EphA2 antagonist | 0.126 0.049 DBMET00493 | DBMET00493 | |
| 0.139 | 0.216 | 0.332 | ErbB-1 antagonist | 0.332 0.025 DBMET00493 | DBMET00493 | |
| 0.014 | 0.093 | 0.034 | Phosphodiesterase 6A inhibitor | 0.028 0.008 DBMET00498 0.034 0.005 DBMET00499 0.034 0.005 DBMET00493 | DBMET00493 | |
| 0.088 | 0.168 | 0.135 | Cell wall synthesis inhibitor | 0.117 0.103 DBMET00499 0.135 0.08 DBMET00493 | DBMET00493 | |
| 0.232 | 0.32 | 0.504 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.344 0.158 DBMET00498 0.473 0.047 DBMET00499 0.504 0.032 DBMET00493 | DBMET00493 | |
| 0.103 | 0.195 | 0.259 | I kappa B kinase epsilon inhibitor | 0.259 0.033 DBMET00493 | DBMET00493 | |
| 0.047 | 0.141 | 0.112 | Interferon agonist | 0.112 0.021 DBMET00498 | DBMET00498 | |
| 0.035 | 0.137 | 0.422 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.397 0.005 DBMET00499 0.422 0.005 DBMET00493 | DBMET00493 | |
| 0.017 | 0.119 | 0.091 | DNA polymerase III inhibitor | 0.091 0.002 DBMET00498 0.062 0.003 DBMET00499 0.037 0.006 DBMET00493 | DBMET00498 | |
| 0.007 | 0.11 | 0.025 | CDK2/cyclin A3 inhibitor | 0.025 0.004 DBMET00493 | DBMET00493 | |
| 0.011 | 0.119 | 0.082 | Nicotinic acid receptor agonist | 0.082 0.006 DBMET00499 0.032 0.03 DBMET00493 | DBMET00499 | |
| 0.054 | 0.163 | 0.085 | Triose-phosphate isomerase inhibitor | 0.085 0.068 DBMET00493 | DBMET00493 | |
| 0.139 | 0.253 | 0.295 | Nitric-oxide synthase stimulant | 0.206 0.079 DBMET00498 0.277 0.018 DBMET00499 0.295 0.013 DBMET00493 | DBMET00493 | |
| 0.033 | 0.148 | 0.064 | Glucosylceramidase inhibitor | 0.064 0.026 DBMET00498 | DBMET00498 | |
| 0.061 | 0.18 | 0.112 | Multidrug resistance-associated protein 1 inhibitor | 0.112 0.059 DBMET00493 | DBMET00493 | |
| 0.056 | 0.175 | 0.101 | Lanosterol 14 alpha demethylase inhibitor | 0.101 0.054 DBMET00493 | DBMET00493 | |
| 0.03 | 0.153 | 0.124 | Histidine decarboxylase inhibitor | 0.079 0.043 DBMET00499 0.124 0.025 DBMET00493 | DBMET00493 | |
| 0.036 | 0.165 | 0.568 | Cyclin-dependent kinase 1 inhibitor | 0.308 0.011 DBMET00499 0.568 0.004 DBMET00493 | DBMET00493 | |
| 0.056 | 0.188 | 0.176 | GABA C receptor antagonist | 0.124 0.049 DBMET00498 0.152 0.029 DBMET00499 0.176 0.019 DBMET00493 | DBMET00493 | |
| 0.034 | 0.172 | 0.076 | Corticotropin releasing factor 2 receptor antagonist | 0.076 0.021 DBMET00499 0.065 0.036 DBMET00493 | DBMET00499 | |
| 0.056 | 0.194 | 0.166 | MAP kinase kinase 1 inhibitor | 0.103 0.053 DBMET00498 0.114 0.041 DBMET00499 0.166 0.011 DBMET00493 | DBMET00493 | |
| 0.086 | 0.227 | 0.214 | GABA C receptor rho-2 antagonist | 0.14 0.087 DBMET00498 0.195 0.032 DBMET00499 0.214 0.022 DBMET00493 | DBMET00493 | |
| 0.015 | 0.168 | 0.295 | Xanthine dehydrogenase inhibitor | 0.295 0.003 DBMET00498 0.154 0.007 DBMET00499 0.1 0.016 DBMET00493 | DBMET00498 | |
| 0.074 | 0.229 | 0.622 | EphB2 antagonist | 0.476 0.009 DBMET00499 0.622 0.004 DBMET00493 | DBMET00493 | |
| 0.052 | 0.207 | 0.148 | AMP-activated protein kinase stimulant | 0.148 0.029 DBMET00498 | DBMET00498 | |
| 0.053 | 0.209 | 0.167 | Epidermal growth factor receptor kinase inhibitor | 0.167 0.038 DBMET00493 | DBMET00493 | |
| 0.018 | 0.175 | 0.116 | Alcohol oxidase inhibitor | 0.053 0.042 DBMET00498 0.082 0.023 DBMET00499 0.116 0.015 DBMET00493 | DBMET00493 | |
| 0.143 | 0.302 | 0.546 | GABA C receptor rho-3 antagonist | 0.378 0.072 DBMET00498 0.454 0.04 DBMET00499 0.546 0.015 DBMET00493 | DBMET00493 | |
| 0.109 | 0.273 | 0.142 | Ca2+-transporting ATPase inhibitor | 0.132 0.108 DBMET00498 0.13 0.122 DBMET00499 0.142 0.066 DBMET00493 | DBMET00493 | |
| 0.132 | 0.297 | 0.274 | Insulysin inhibitor | 0.205 0.149 DBMET00499 0.274 0.076 DBMET00493 | DBMET00493 | |
| 0.04 | 0.205 | 0.08 | GABA A receptor agonist | 0.08 0.063 DBMET00493 | DBMET00493 | |
| 0.039 | 0.205 | 0.166 | Platelet activating factor antagonist | 0.166 0.037 DBMET00493 | DBMET00493 | |
| 0.046 | 0.217 | 0.1 | GABA receptor agonist | 0.1 0.077 DBMET00493 | DBMET00493 | |
| 0.002 | 0.175 | 0.007 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.007 0.006 DBMET00498 | DBMET00498 | |
| 0.034 | 0.213 | 0.355 | Check point kinase 2 inhibitor | 0.089 0.075 DBMET00499 0.355 0.005 DBMET00493 | DBMET00493 | |
| 0.01 | 0.194 | 0.385 | Phosphodiesterase 2A inhibitor | 0.385 0.002 DBMET00498 0.096 0.009 DBMET00499 0.051 0.032 DBMET00493 | DBMET00498 | |
| 0.085 | 0.269 | 0.192 | CF transmembrane conductance regulator agonist | 0.171 0.046 DBMET00499 0.192 0.027 DBMET00493 | DBMET00493 | |
| 0.173 | 0.358 | 0.402 | 5 Hydroxytryptamine release inhibitor | 0.243 0.238 DBMET00499 0.402 0.077 DBMET00493 | DBMET00493 | |
| 0.01 | 0.198 | 0.394 | Phosphodiesterase II inhibitor | 0.394 0.002 DBMET00498 0.117 0.008 DBMET00499 0.067 0.026 DBMET00493 | DBMET00498 | |
| 0.034 | 0.227 | 0.315 | CDK2/cyclin A inhibitor | 0.115 0.046 DBMET00499 0.315 0.006 DBMET00493 | DBMET00493 | |
| 0.022 | 0.222 | 0.131 | Porphobilinogen synthase inhibitor | 0.072 0.054 DBMET00499 0.131 0.025 DBMET00493 | DBMET00493 | |
| 0.046 | 0.248 | 0.115 | Cyclin-dependent kinase 7 inhibitor | 0.115 0.089 DBMET00493 | DBMET00493 | |
| 0.028 | 0.233 | 0.089 | Alpha 1b adrenoreceptor agonist | 0.067 0.014 DBMET00499 0.089 0.006 DBMET00493 | DBMET00493 | |
| 0.058 | 0.267 | 0.112 | CDK3/cyclin E inhibitor | 0.112 0.067 DBMET00493 | DBMET00493 | |
| 0.029 | 0.243 | 0.203 | Protein kinase B gamma inhibitor | 0.203 0.008 DBMET00498 0.076 0.051 DBMET00499 | DBMET00498 | |
| 0.028 | 0.243 | 0.22 | MAP kinase kinase kinase inhibitor | 0.112 0.056 DBMET00499 0.22 0.014 DBMET00493 | DBMET00493 | |
| 0.023 | 0.24 | 0.077 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.077 0.075 DBMET00493 | DBMET00493 | |
| 0.042 | 0.259 | 0.431 | Ribosomal protein S6 kinase inhibitor | 0.431 0.005 DBMET00499 0.386 0.005 DBMET00493 | DBMET00499 | |
| 0.014 | 0.232 | 0.051 | Glutamate (mGluR1a) antagonist | 0.051 0.02 DBMET00493 | DBMET00493 | |
| 0.056 | 0.281 | 0.103 | Interleukin 8 antagonist | 0.103 0.09 DBMET00499 | DBMET00499 | |
| 0.153 | 0.379 | 0.405 | MAP kinase kinase 6 inhibitor | 0.31 0.126 DBMET00498 0.405 0.055 DBMET00493 | DBMET00493 | |
| 0.021 | 0.25 | 0.164 | Platelet activating factor beta antagonist | 0.085 0.075 DBMET00499 0.164 0.033 DBMET00493 | DBMET00493 | |
| 0.025 | 0.255 | 0.296 | CDK/cyclin complex inhibitor | 0.296 0.01 DBMET00493 | DBMET00493 | |
| 0.024 | 0.256 | 0.06 | Carbonic anhydrase II stimulant | 0.054 0.032 DBMET00499 0.06 0.023 DBMET00493 | DBMET00493 | |
| 0.013 | 0.248 | 0.224 | Phosphodiesterase 4C inhibitor | 0.224 0.005 DBMET00498 0.144 0.008 DBMET00499 0.182 0.005 DBMET00493 | DBMET00498 | |
| 0.006 | 0.242 | 0.031 | Potassium channel small-conductance Ca-activated activator | 0.031 0.022 DBMET00493 | DBMET00493 | |
| 0.019 | 0.256 | 0.09 | CDK2/cyclin E2 inhibitor | 0.09 0.032 DBMET00493 | DBMET00493 | |
| 0.017 | 0.258 | 0.086 | Syk tyrosine kinase inhibitor | 0.086 0.036 DBMET00493 | DBMET00493 | |
| 0.007 | 0.252 | 0.059 | Dihydropteroate synthase inhibitor | 0.059 0.012 DBMET00498 0.059 0.012 DBMET00493 | DBMET00493 | |
| 0.01 | 0.255 | 0.369 | Phosphatidylinositol 3-kinase delta inhibitor | 0.073 0.028 DBMET00499 0.369 0.004 DBMET00493 | DBMET00493 | |
| 0.002 | 0.249 | 0.031 | Egl nine homolog 3 inhibitor | 0.025 0.004 DBMET00498 0.031 0.003 DBMET00499 0.021 0.004 DBMET00493 | DBMET00499 | |
| 0.025 | 0.284 | 0.289 | Protein-tyrosine kinase Lyn inhibitor | 0.139 0.072 DBMET00499 0.289 0.021 DBMET00493 | DBMET00493 | |
| 0.029 | 0.302 | 0.089 | Phosphodiesterase 1C inhibitor | 0.082 0.018 DBMET00498 0.089 0.014 DBMET00499 0.079 0.02 DBMET00493 | DBMET00499 | |
| 0.028 | 0.303 | 0.201 | Lck kinase inhibitor | 0.103 0.099 DBMET00499 0.201 0.04 DBMET00493 | DBMET00493 | |
| 0.006 | 0.284 | 0.031 | Glutaminyl-peptide cyclotransferase inhibitor | 0.031 0.006 DBMET00499 0.023 0.013 DBMET00493 | DBMET00499 | |
| 0.029 | 0.31 | 0.105 | Ephrin antagonist | 0.105 0.059 DBMET00499 0.103 0.061 DBMET00493 | DBMET00499 | |
| 0.008 | 0.292 | 0.207 | Raf kinase C inhibitor | 0.207 0.009 DBMET00493 | DBMET00493 | |
| 0.03 | 0.315 | 0.249 | Ferrochelatase inhibitor | 0.146 0.039 DBMET00498 0.159 0.034 DBMET00499 0.249 0.013 DBMET00493 | DBMET00493 | |
| 0.016 | 0.303 | 0.287 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.287 0.021 DBMET00493 | DBMET00493 | |
| 0.04 | 0.326 | 0.085 | Granulocyte macrophage colony stimulating factor agonist | 0.085 0.063 DBMET00493 | DBMET00493 | |
| 0.026 | 0.317 | 0.1 | Cyclin-dependent kinase 9 inhibitor | 0.1 0.063 DBMET00493 | DBMET00493 | |
| 0.036 | 0.328 | 0.373 | Src kinase inhibitor | 0.181 0.064 DBMET00499 0.373 0.015 DBMET00493 | DBMET00493 | |
| 0.006 | 0.299 | 0.031 | DNA polymerase III polC-type inhibitor | 0.031 0.003 DBMET00499 0.015 0.005 DBMET00493 | DBMET00499 | |
| 0.009 | 0.303 | 0.042 | Stearoyl-CoA desaturase inhibitor | 0.042 0.033 DBMET00499 0.041 0.036 DBMET00493 | DBMET00499 | |
| 0.041 | 0.339 | 0.174 | Activin receptor-like kinase 2 inhibitor | 0.174 0.05 DBMET00493 | DBMET00493 | |
| 0.015 | 0.315 | 0.059 | Histamine H4 receptor antagonist | 0.059 0.019 DBMET00493 | DBMET00493 | |
| 0.083 | 0.388 | 0.223 | MAP-kinase-activated kinase 5 inhibitor | 0.223 0.08 DBMET00499 0.217 0.085 DBMET00493 | DBMET00499 | |
| 0.049 | 0.356 | 0.198 | Aurora-C kinase inhibitor | 0.198 0.02 DBMET00493 | DBMET00493 | |
| 0.012 | 0.319 | 0.052 | EphB4 antagonist | 0.052 0.047 DBMET00499 | DBMET00499 | |
| 0.02 | 0.334 | 0.074 | ErbB-2 antagonist | 0.074 0.054 DBMET00493 | DBMET00493 | |
| 0.006 | 0.322 | 0.032 | Alpha 1a adrenoreceptor agonist | 0.032 0.01 DBMET00493 | DBMET00493 | |
| 0.018 | 0.335 | 0.194 | Platelet activating factor alpha antagonist | 0.194 0.018 DBMET00493 | DBMET00493 | |
| 0.021 | 0.34 | 0.26 | Cyclin-dependent kinase 2 inhibitor | 0.159 0.034 DBMET00499 0.26 0.016 DBMET00493 | DBMET00493 | |
| 0.001 | 0.324 | 0.019 | DNA topoisomerase III inhibitor | 0.019 0.002 DBMET00498 0.011 0.003 DBMET00499 | DBMET00498 | |
| 0.005 | 0.334 | 0.019 | Alpha 2b adrenoreceptor agonist | 0.019 0.014 DBMET00493 | DBMET00493 | |
| 0.03 | 0.36 | 0.805 | Phosphodiesterase inhibitor | 0.805 0.004 DBMET00498 0.625 0.004 DBMET00499 0.292 0.016 DBMET00493 | DBMET00498 | |
| 0.024 | 0.354 | 0.219 | MAP kinase kinase inhibitor | 0.166 0.043 DBMET00499 0.219 0.022 DBMET00493 | DBMET00493 | |
| 0.002 | 0.335 | 0.019 | Egl nine homolog 1 inhibitor | 0.019 0.006 DBMET00498 0.018 0.006 DBMET00499 0.016 0.009 DBMET00493 | DBMET00498 | |
| 0.017 | 0.353 | 0.093 | Bcr-Abl kinase inhibitor | 0.093 0.049 DBMET00493 | DBMET00493 | |
| 0.048 | 0.386 | 0.692 | Aldehyde oxidase inhibitor | 0.692 0.009 DBMET00499 0.57 0.023 DBMET00493 | DBMET00499 | |
| 0.019 | 0.362 | 0.328 | Glycogen synthase kinase-3 beta inhibitor | 0.178 0.034 DBMET00499 0.328 0.011 DBMET00493 | DBMET00493 | |
| 0.008 | 0.353 | 0.549 | Raf kinase inhibitor | 0.383 0.005 DBMET00499 0.549 0.004 DBMET00493 | DBMET00493 | |
| 0.02 | 0.367 | 0.335 | Glycogen synthase kinase-3 inhibitor | 0.187 0.034 DBMET00499 0.335 0.013 DBMET00493 | DBMET00493 | |
| 0.034 | 0.383 | 0.101 | mTOR complex 2 inhibitor | 0.09 0.047 DBMET00499 0.101 0.032 DBMET00493 | DBMET00493 | |
| 0.017 | 0.367 | 0.083 | Epidermal growth factor antagonist | 0.083 0.062 DBMET00493 | DBMET00493 | |
| 0.016 | 0.368 | 0.105 | Glutamate (mGluR4) antagonist | 0.105 0.005 DBMET00499 0.077 0.009 DBMET00493 | DBMET00499 | |
| 0.013 | 0.371 | 0.05 | mTOR inhibitor | 0.05 0.038 DBMET00499 0.046 0.043 DBMET00493 | DBMET00499 | |
| 0.005 | 0.366 | 0.446 | Raf kinase B inhibitor | 0.371 0.005 DBMET00499 0.446 0.004 DBMET00493 | DBMET00493 | |
| 0.014 | 0.375 | 0.039 | Kainate receptor agonist | 0.039 0.035 DBMET00498 | DBMET00498 | |
| 0.069 | 0.432 | 0.31 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.144 0.143 DBMET00499 0.31 0.027 DBMET00493 | DBMET00493 | |
| 0.04 | 0.404 | 0.209 | Peroxidase inhibitor | 0.142 0.082 DBMET00498 0.136 0.086 DBMET00499 0.209 0.057 DBMET00493 | DBMET00493 | |
| 0.027 | 0.396 | 0.215 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.215 0.084 DBMET00499 0.183 0.104 DBMET00493 | DBMET00499 | |
| 0.022 | 0.392 | 0.116 | Creatine kinase inhibitor | 0.116 0.044 DBMET00493 | DBMET00493 | |
| 0.056 | 0.43 | 0.204 | Growth hormone agonist | 0.204 0.057 DBMET00499 | DBMET00499 | |
| 0.012 | 0.388 | 0.126 | Phenylalanine 4-hydroxylase inhibitor | 0.126 0.016 DBMET00498 0.082 0.036 DBMET00499 0.1 0.026 DBMET00493 | DBMET00498 | |
| 0.018 | 0.395 | 0.054 | Cyclin H inhibitor | 0.054 0.048 DBMET00493 | DBMET00493 | |
| 0.049 | 0.426 | 0.161 | Succinate dehydrogenase inhibitor | 0.161 0.093 DBMET00498 0.154 0.104 DBMET00493 | DBMET00498 | |
| 0.033 | 0.413 | 0.311 | Phosphodiesterase 7B inhibitor | 0.311 0.004 DBMET00499 0.205 0.01 DBMET00493 | DBMET00499 | |
| 0.01 | 0.395 | 0.214 | Protein kinase (CK2) inhibitor | 0.214 0.016 DBMET00499 0.169 0.026 DBMET00493 | DBMET00499 | |
| 0.037 | 0.423 | 0.115 | Interleukin 1 antagonist | 0.115 0.096 DBMET00498 | DBMET00498 | |
| 0.016 | 0.406 | 0.073 | Sirtuin 1 inhibitor | 0.073 0.041 DBMET00499 | DBMET00499 | |
| 0.011 | 0.403 | 0.09 | Phosphatidylinositol kinase inhibitor | 0.09 0.024 DBMET00493 | DBMET00493 | |
| 0.01 | 0.402 | 0.585 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.408 0.005 DBMET00499 0.585 0.004 DBMET00493 | DBMET00493 | |
| 0.011 | 0.405 | 0.183 | Cyclin-dependent kinase 5 inhibitor | 0.124 0.055 DBMET00499 0.183 0.027 DBMET00493 | DBMET00493 | |
| 0.016 | 0.411 | 0.138 | Protein kinase B beta inhibitor | 0.069 0.058 DBMET00498 0.12 0.015 DBMET00499 0.138 0.009 DBMET00493 | DBMET00493 | |
| 0.008 | 0.404 | 0.063 | Histamine H1 receptor agonist | 0.053 0.015 DBMET00499 0.063 0.007 DBMET00493 | DBMET00493 | |
| 0.028 | 0.426 | 0.281 | MAP kinase kinase 2 inhibitor | 0.158 0.114 DBMET00499 0.281 0.042 DBMET00493 | DBMET00493 | |
| 0.008 | 0.407 | 0.055 | Bruton tyrosine kinase inhibitor | 0.055 0.041 DBMET00493 | DBMET00493 | |
| 0.01 | 0.411 | 0.087 | Leucine-rich repeat kinase 2 inhibitor | 0.087 0.052 DBMET00493 | DBMET00493 | |
| 0.025 | 0.427 | 0.301 | Diuretic | 0.301 0.022 DBMET00499 0.208 0.041 DBMET00493 | DBMET00499 | |
| 0.023 | 0.428 | 0.214 | Dyrk kinase inhibitor | 0.214 0.091 DBMET00499 0.187 0.106 DBMET00493 | DBMET00499 | |
| 0.009 | 0.415 | 0.106 | Cyclin A2 inhibitor | 0.065 0.043 DBMET00499 0.106 0.023 DBMET00493 | DBMET00493 | |
| 0.02 | 0.426 | 0.106 | MAP-kinase-activated kinase inhibitor | 0.106 0.034 DBMET00499 | DBMET00499 | |
| 0.009 | 0.417 | 0.027 | Complement factor 1s inhibitor | 0.027 0.014 DBMET00493 | DBMET00493 | |
| 0.013 | 0.421 | 0.371 | RET inhibitor | 0.28 0.026 DBMET00499 0.371 0.012 DBMET00493 | DBMET00493 | |
| 0.005 | 0.413 | 0.043 | CDK5/p25 inhibitor | 0.042 0.027 DBMET00499 0.043 0.027 DBMET00493 | DBMET00493 | |
| 0.005 | 0.415 | 0.086 | Alpha 1d adrenoreceptor agonist | 0.057 0.012 DBMET00499 0.086 0.005 DBMET00493 | DBMET00493 | |
| 0.004 | 0.414 | 0.032 | Nicotinic acid receptor 2 antagonist | 0.032 0.011 DBMET00499 | DBMET00499 | |
| 0.013 | 0.425 | 0.071 | Carbonic anhydrase stimulant | 0.059 0.041 DBMET00499 0.071 0.031 DBMET00493 | DBMET00493 | |
| 0.012 | 0.425 | 0.368 | c-Src kinase inhibitor | 0.195 0.037 DBMET00499 0.368 0.01 DBMET00493 | DBMET00493 | |
| 0.014 | 0.428 | 0.102 | Platelet growth factor antagonist | 0.102 0.039 DBMET00493 | DBMET00493 | |
| 0.017 | 0.433 | 0.062 | Dihydroorotate oxidase inhibitor | 0.062 0.026 DBMET00499 | DBMET00499 | |
| 0.027 | 0.445 | 0.119 | Electrolyte absorption antagonist | 0.113 0.043 DBMET00499 0.119 0.037 DBMET00493 | DBMET00493 | |
| 0.008 | 0.426 | 0.061 | Histamine agonist | 0.05 0.039 DBMET00499 0.061 0.026 DBMET00493 | DBMET00493 | |
| 0.018 | 0.438 | 0.088 | Polo-like kinase-1 inhibitor | 0.088 0.065 DBMET00499 | DBMET00499 | |
| 0.019 | 0.439 | 0.169 | Vascular endothelial growth factor 3 antagonist | 0.169 0.055 DBMET00493 | DBMET00493 | |
| 0.03 | 0.451 | 0.146 | Mannose-6-phosphate isomerase inhibitor | 0.146 0.068 DBMET00498 | DBMET00498 | |
| 0.019 | 0.44 | 0.225 | Cyclin-dependent kinase inhibitor | 0.155 0.054 DBMET00499 0.225 0.032 DBMET00493 | DBMET00493 | |
| 0.006 | 0.433 | 0.046 | Glutamate (mGluR3) antagonist | 0.046 0.015 DBMET00498 | DBMET00498 | |
| 0.009 | 0.442 | 0.059 | Fibroblast growth factor 2 antagonist | 0.059 0.054 DBMET00493 | DBMET00493 | |
| 0.018 | 0.455 | 0.062 | Histone deacetylase SIRT3 inhibitor | 0.062 0.043 DBMET00493 | DBMET00493 | |
| 0.012 | 0.451 | 0.035 | Transforming growth factor beta 2 antagonist | 0.034 0.021 DBMET00499 0.035 0.018 DBMET00493 | DBMET00493 | |
| 0.005 | 0.445 | 0.085 | Phosphodiesterase 4A inhibitor | 0.085 0.019 DBMET00499 0.078 0.021 DBMET00493 | DBMET00499 | |
| 0.018 | 0.461 | 0.128 | Cystathionine beta-synthase inhibitor | 0.128 0.052 DBMET00498 | DBMET00498 | |
| 0.011 | 0.454 | 0.083 | Pim-1 kinase inhibitor | 0.083 0.077 DBMET00493 | DBMET00493 | |
| 0.009 | 0.453 | 0.059 | Protein kinase (CK2) beta inhibitor | 0.031 0.028 DBMET00498 0.059 0.005 DBMET00499 | DBMET00499 | |
| 0.007 | 0.452 | 0.075 | Histamine H2 receptor agonist | 0.058 0.016 DBMET00499 0.075 0.009 DBMET00493 | DBMET00493 | |
| 0.011 | 0.456 | 0.175 | TIE-2 antagonist | 0.175 0.018 DBMET00493 | DBMET00493 | |
| 0.017 | 0.463 | 0.199 | Clk dual-specificity kinase inhibitor | 0.199 0.08 DBMET00499 0.194 0.083 DBMET00493 | DBMET00499 | |
| 0.017 | 0.466 | 0.509 | Bronchodilator | 0.509 0.004 DBMET00499 0.334 0.008 DBMET00493 | DBMET00499 | |
| 0.004 | 0.456 | 0.066 | Glutamate (mGluR1) antagonist | 0.066 0.033 DBMET00493 | DBMET00493 | |
| 0.014 | 0.465 | 0.083 | MAP-kinase-activated kinase 2 inhibitor | 0.083 0.041 DBMET00499 | DBMET00499 | |
| 0.014 | 0.467 | 0.177 | Abl kinase inhibitor | 0.177 0.035 DBMET00493 | DBMET00493 | |
| 0.012 | 0.465 | 0.194 | Glycogen synthase kinase-3 alpha inhibitor | 0.194 0.043 DBMET00499 0.128 0.079 DBMET00493 | DBMET00499 | |
| 0.015 | 0.468 | 0.177 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.177 0.035 DBMET00493 | DBMET00493 | |
| 0.017 | 0.471 | 0.129 | AXL receptor tyrosine kinase inhibitor | 0.129 0.024 DBMET00493 | DBMET00493 | |
| 0.01 | 0.465 | 0.178 | TIE antagonist | 0.178 0.018 DBMET00493 | DBMET00493 | |
| 0.004 | 0.459 | 0.126 | AMPA receptor antagonist | 0.126 0.008 DBMET00498 0.059 0.025 DBMET00499 | DBMET00498 | |
| 0.004 | 0.47 | 0.029 | Protocollagen prolyl hydroxylase inhibitor | 0.029 0.016 DBMET00493 | DBMET00493 | |
| 0.006 | 0.472 | 0.074 | Fibroblast growth factor 3 antagonist | 0.074 0.059 DBMET00493 | DBMET00493 | |
| 0.013 | 0.479 | 0.055 | Glutamate (mGluR group III) antagonist | 0.055 0.016 DBMET00499 0.05 0.021 DBMET00493 | DBMET00499 | |
| 0.007 | 0.476 | 0.093 | Cyclin A inhibitor | 0.055 0.048 DBMET00499 0.093 0.025 DBMET00493 | DBMET00493 | |
| 0.009 | 0.483 | 0.032 | LIM domain kinase 2 inhibitor | 0.032 0.019 DBMET00493 | DBMET00493 | |
| 0.002 | 0.48 | 0.017 | Alpha 2c adrenoreceptor agonist | 0.017 0.016 DBMET00493 | DBMET00493 | |
| 0.097 | 0.575 | 0.263 | 5 Hydroxytryptamine 3E antagonist | 0.227 0.03 DBMET00499 0.263 0.011 DBMET00493 | DBMET00493 | |
| 0.02 | 0.501 | 0.093 | Exportin-1 inhibitor | 0.08 0.025 DBMET00499 0.093 0.013 DBMET00493 | DBMET00493 | |
| 0.004 | 0.494 | 0.032 | MAP3K8 inhibitor | 0.032 0.014 DBMET00493 | DBMET00493 | |
| 0.023 | 0.513 | 0.338 | Tyrosine kinase inhibitor | 0.338 0.036 DBMET00493 | DBMET00493 | |
| 0.012 | 0.504 | 0.081 | Phospholipase D inhibitor | 0.081 0.033 DBMET00498 0.073 0.048 DBMET00499 0.069 0.056 DBMET00493 | DBMET00498 | |
| 0.005 | 0.502 | 0.138 | Phosphodiesterase 4D inhibitor | 0.094 0.04 DBMET00498 0.138 0.022 DBMET00499 0.133 0.023 DBMET00493 | DBMET00499 | |
| 0.013 | 0.515 | 0.181 | Vascular endothelial growth factor antagonist | 0.181 0.044 DBMET00493 | DBMET00493 | |
| 0.031 | 0.533 | 0.165 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.165 0.099 DBMET00499 | DBMET00499 | |
| 0.075 | 0.58 | 0.215 | Tyrosine 3 hydroxylase inhibitor | 0.215 0.11 DBMET00498 0.214 0.112 DBMET00493 | DBMET00498 | |
| 0.009 | 0.518 | 0.156 | Vascular endothelial growth factor 2 antagonist | 0.156 0.047 DBMET00493 | DBMET00493 | |
| 0.023 | 0.532 | 0.153 | Insulin sensitizer | 0.153 0.129 DBMET00493 | DBMET00493 | |
| 0.005 | 0.515 | 0.058 | Dihydroorotate dehydrogenase inhibitor | 0.058 0.03 DBMET00499 | DBMET00499 | |
| 0.021 | 0.534 | 0.421 | Prostaglandin dehydrogenase inhibitor | 0.421 0.061 DBMET00498 | DBMET00498 | |
| 0.012 | 0.526 | 0.056 | Heat shock protein 90 beta antagonist | 0.056 0.047 DBMET00493 | DBMET00493 | |
| 0.002 | 0.518 | 0.009 | CXC chemokine 3 receptor agonist | 0.009 0.008 DBMET00493 | DBMET00493 | |
| 0.005 | 0.521 | 0.15 | Protein kinase (CK2) alpha inhibitor | 0.116 0.064 DBMET00499 0.15 0.042 DBMET00493 | DBMET00493 | |
| 0.011 | 0.529 | 0.042 | Somatostatin 4 agonist | 0.042 0.02 DBMET00493 | DBMET00493 | |
| 0.008 | 0.527 | 0.192 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.192 0.006 DBMET00499 0.174 0.008 DBMET00493 | DBMET00499 | |
| 0.009 | 0.53 | 0.109 | Fibroblast growth factor 1 antagonist | 0.109 0.051 DBMET00493 | DBMET00493 | |
| 0.008 | 0.529 | 0.041 | Tryptophan 5 hydroxylase inhibitor | 0.041 0.014 DBMET00498 0.034 0.032 DBMET00499 | DBMET00498 | |
| 0.023 | 0.546 | 0.094 | DOPA decarboxylase inhibitor | 0.094 0.089 DBMET00498 | DBMET00498 | |
| 0.006 | 0.532 | 0.128 | Phosphodiesterase VII inhibitor | 0.128 0.005 DBMET00499 0.064 0.041 DBMET00493 | DBMET00499 | |
| 0.013 | 0.542 | 0.118 | Vascular endothelial growth factor 1 antagonist | 0.118 0.055 DBMET00493 | DBMET00493 | |
| 0.011 | 0.544 | 0.18 | CDC-like kinase 4 inhibitor | 0.18 0.079 DBMET00499 0.156 0.096 DBMET00493 | DBMET00499 | |
| 0.018 | 0.552 | 0.296 | MAP kinase 12 inhibitor | 0.166 0.034 DBMET00498 0.296 0.007 DBMET00499 0.188 0.026 DBMET00493 | DBMET00499 | |
| 0.015 | 0.554 | 0.141 | Growth factor antagonist | 0.141 0.075 DBMET00493 | DBMET00493 | |
| 0.004 | 0.542 | 0.026 | Acid ceramidase inhibitor | 0.026 0.017 DBMET00499 | DBMET00499 | |
| 0.014 | 0.559 | 0.115 | Myeloperoxidase inhibitor | 0.115 0.022 DBMET00499 0.115 0.022 DBMET00493 | DBMET00493 | |
| 0.01 | 0.569 | 0.032 | ATR kinase inhibitor | 0.032 0.026 DBMET00493 | DBMET00493 | |
| 0.005 | 0.564 | 0.107 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.107 0.051 DBMET00493 | DBMET00493 | |
| 0.007 | 0.566 | 0.18 | Protein kinase (CK1) inhibitor | 0.149 0.068 DBMET00499 0.18 0.048 DBMET00493 | DBMET00493 | |
| 0.015 | 0.574 | 0.071 | GABA B receptor agonist | 0.071 0.065 DBMET00493 | DBMET00493 | |
| 0.026 | 0.586 | 0.12 | mTOR complex 1 inhibitor | 0.12 0.029 DBMET00499 0.112 0.04 DBMET00493 | DBMET00499 | |
| 0.004 | 0.575 | 0.075 | GABA receptor antagonist | 0.075 0.024 DBMET00498 | DBMET00498 | |
| 0.029 | 0.604 | 0.351 | 15-Lipoxygenase inhibitor | 0.351 0.099 DBMET00498 | DBMET00498 | |
| 0.007 | 0.585 | 0.093 | CDC7 inhibitor | 0.069 0.045 DBMET00499 0.093 0.028 DBMET00493 | DBMET00493 | |
| 0.011 | 0.589 | 0.138 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.138 0.072 DBMET00499 | DBMET00499 | |
| 0.005 | 0.585 | 0.102 | Janus tyrosine kinase 3 inhibitor | 0.102 0.032 DBMET00493 | DBMET00493 | |
| 0.013 | 0.595 | 0.09 | Phosphodiesterase XI inhibitor | 0.09 0.042 DBMET00493 | DBMET00493 | |
| 0.013 | 0.595 | 0.09 | Phosphodiesterase 11A inhibitor | 0.09 0.042 DBMET00493 | DBMET00493 | |
| 0.004 | 0.588 | 0.076 | GABA A receptor antagonist | 0.076 0.023 DBMET00498 | DBMET00498 | |
| 0.021 | 0.609 | 0.31 | DNA polymerase beta inhibitor | 0.31 0.16 DBMET00498 | DBMET00498 | |
| 0.008 | 0.597 | 0.125 | CDC-like kinase 2 inhibitor | 0.125 0.114 DBMET00493 | DBMET00493 | |
| 0.049 | 0.639 | 0.458 | MAP kinase 1 inhibitor | 0.458 0.073 DBMET00498 0.25 0.233 DBMET00499 | DBMET00498 | |
| 0.019 | 0.611 | 0.245 | Interleukin antagonist | 0.245 0.064 DBMET00498 | DBMET00498 | |
| 0.018 | 0.613 | 0.124 | Heat shock protein 90 antagonist | 0.124 0.108 DBMET00493 | DBMET00493 | |
| 0.006 | 0.603 | 0.097 | Granulocyte macrophage colony stimulating factor antagonist | 0.097 0.075 DBMET00499 0.093 0.08 DBMET00493 | DBMET00499 | |
| 0.018 | 0.617 | 0.158 | HIV-1 integrase (Overall Integration) inhibitor | 0.158 0.022 DBMET00498 | DBMET00498 | |
| 0.008 | 0.61 | 0.188 | Glutamate receptor antagonist | 0.188 0.03 DBMET00498 | DBMET00498 | |
| 0.008 | 0.611 | 0.234 | LIM domain kinase 1 inhibitor | 0.202 0.062 DBMET00499 0.234 0.046 DBMET00493 | DBMET00493 | |
| 0.014 | 0.623 | 0.38 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.38 0.009 DBMET00498 | DBMET00498 | |
| 0.031 | 0.64 | 0.231 | Tumour necrosis factor antagonist | 0.231 0.037 DBMET00499 | DBMET00499 | |
| 0.008 | 0.63 | 0.045 | Dopamine beta hydroxylase inhibitor | 0.045 0.042 DBMET00493 | DBMET00493 | |
| 0.009 | 0.637 | 0.135 | Anesthetic general | 0.135 0.131 DBMET00499 | DBMET00499 | |
| 0.012 | 0.643 | 0.262 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.262 0.044 DBMET00499 | DBMET00499 | |
| 0.006 | 0.638 | 0.086 | Protein kinase B alpha inhibitor | 0.086 0.037 DBMET00493 | DBMET00493 | |
| 0.004 | 0.638 | 0.083 | Pim-3 kinase inhibitor | 0.083 0.071 DBMET00499 | DBMET00499 | |
| 0.018 | 0.654 | 0.153 | Nav1.3 sodium channel blocker | 0.13 0.064 DBMET00499 0.153 0.046 DBMET00493 | DBMET00493 | |
| 0.019 | 0.659 | 0.191 | Focal adhesion kinase 2 inhibitor | 0.191 0.077 DBMET00493 | DBMET00493 | |
| 0.024 | 0.671 | 0.355 | Angiogenesis inhibitor | 0.355 0.069 DBMET00493 | DBMET00493 | |
| 0.03 | 0.686 | 0.195 | Superoxide dismutase inhibitor | 0.195 0.123 DBMET00499 0.176 0.147 DBMET00493 | DBMET00499 | |
| 0.003 | 0.663 | 0.086 | Calcitonin gene-related peptide antagonist | 0.066 0.005 DBMET00498 0.086 0.003 DBMET00499 | DBMET00499 | |
| 0.013 | 0.678 | 0.144 | Cyclin-dependent kinase 8 inhibitor | 0.144 0.086 DBMET00499 0.121 0.116 DBMET00493 | DBMET00499 | |
| 0.008 | 0.677 | 0.086 | Caspase 7 inhibitor | 0.086 0.049 DBMET00498 | DBMET00498 | |
| 0.003 | 0.674 | 0.027 | Kainate receptor 4 antagonist | 0.027 0.016 DBMET00498 | DBMET00498 | |
| 0.01 | 0.68 | 0.043 | CC chemokine 4 receptor antagonist | 0.043 0.04 DBMET00499 | DBMET00499 | |
| 0.026 | 0.701 | 0.556 | Toll-Like receptor agonist | 0.556 0.023 DBMET00499 0.507 0.03 DBMET00493 | DBMET00499 | |
| 0.026 | 0.704 | 0.566 | Toll-Like receptor 7 agonist | 0.566 0.021 DBMET00499 0.516 0.029 DBMET00493 | DBMET00499 | |
| 0.007 | 0.694 | 0.151 | Polo-like kinase-4 inhibitor | 0.151 0.035 DBMET00499 0.129 0.049 DBMET00493 | DBMET00499 | |
| 0.004 | 0.721 | 0.08 | Nicotinic acid receptor 2 agonist | 0.08 0.008 DBMET00499 | DBMET00499 | |
| 0.011 | 0.73 | 0.193 | Polo-like kinase-3 inhibitor | 0.193 0.049 DBMET00499 | DBMET00499 | |
| 0.005 | 0.723 | 0.155 | Aurora-A kinase inhibitor | 0.155 0.038 DBMET00493 | DBMET00493 | |
| 0.014 | 0.737 | 0.123 | Sphingosine 1-phosphate receptor 5 antagonist | 0.123 0.118 DBMET00498 | DBMET00498 | |
| 0.008 | 0.745 | 0.248 | Alpha-glucosidase inhibitor | 0.248 0.188 DBMET00498 | DBMET00498 | |
| 0.003 | 0.752 | 0.191 | Phosphodiesterase IV inhibitor | 0.117 0.034 DBMET00498 0.191 0.014 DBMET00499 0.076 0.066 DBMET00493 | DBMET00499 | |
| 0.005 | 0.754 | 0.117 | Protein kinase (CK1) gamma inhibitor | 0.117 0.093 DBMET00499 | DBMET00499 | |
| 0.013 | 0.766 | 0.178 | Thyroid hormone beta antagonist | 0.178 0.175 DBMET00498 | DBMET00498 | |
| 0.002 | 0.757 | 0.041 | NMDA receptor subunit 3A antagonist | 0.041 0.024 DBMET00498 | DBMET00498 | |
| 0.012 | 0.769 | 0.186 | Thyroid hormone antagonist | 0.186 0.174 DBMET00498 | DBMET00498 | |
| 0.002 | 0.776 | 0.118 | Calcitonin gene-related peptide 1 receptor antagonist | 0.115 0.004 DBMET00498 0.118 0.003 DBMET00499 | DBMET00499 | |
| 0.003 | 0.782 | 0.137 | NMDA receptor antagonist | 0.137 0.029 DBMET00498 | DBMET00498 | |
| 0.002 | 0.783 | 0.062 | NMDA receptor subunit 3B antagonist | 0.062 0.018 DBMET00498 | DBMET00498 | |
| 0.009 | 0.818 | 0.115 | M18 aspartyl aminopeptidase inhibitor | 0.115 0.075 DBMET00499 | DBMET00499 | |
| 0.005 | 0.815 | 0.086 | Bromodomain-containing protein 2 inhibitor | 0.086 0.064 DBMET00499 | DBMET00499 | |
| 0.018 | 0.852 | 0.191 | Heme oxygenase stimulant | 0.191 0.002 DBMET00498 | DBMET00498 | |
| 0.014 | 0.861 | 0.165 | Interleukin 5 antagonist | 0.165 0.008 DBMET00498 | DBMET00498 | |
| 0.004 | 0.857 | 0.23 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.23 0.085 DBMET00498 | DBMET00498 | |
| 0.005 | 0.896 | 0.113 | M17 leucyl aminopeptidase inhibitor | 0.113 0.084 DBMET00498 | DBMET00498 | |
| 0.014 | 0.908 | 0.565 | Interleukin 4 antagonist | 0.565 0.004 DBMET00498 | DBMET00498 | |
| 0.005 | 0.945 | 0.31 | Streptokinase A inhibitor | 0.31 0.075 DBMET00498 | DBMET00498 | |
| 0.004 | 0.973 | 0.367 | Thioredoxin glutathione reductase inhibitor | 0.367 0.07 DBMET00498 | DBMET00498 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |